Before shortlisting ActivSight, verify the hospital’s existing imaging stack
A U.S. procurement check for exact configurations, labeling and downtime support, not a clinical recommendation.
Activ Surgical’s ActivSight is an imaging accessory for existing laparoscopic systems. In 2023, the U.S. FDA issued a 510(k) substantial equivalence determination for the ActivSight Intraoperative Imaging System (K231344). Its labeling rules out standalone use for bile duct visualization. This is not a comparison of clinical outcomes or a clearance for every imaging stack.
Verify the configuration before requesting a quote
Ask the vendor for exact model numbers and corresponding labeling, and written confirmation that the hospital’s cameras, processors and towers work together with that configuration. Have clinical engineering and sterile processing review required accessories, turnaround capacity and responsibilities. Request a patient-free bench demonstration of startup checks, downtime alerts and service escalation, not a surgical procedure.
Know when to defer
If the demonstration uses a different model, or service response, replacement equipment and training are unclear, pause before negotiating. Include initial rollout, training and downtime coverage in the comparison. With compatibility and support documented, refer it to the hospital equipment committee. Local regulatory requirements and actual use are subject to independent institutional review.
Content note:This article is based on publicly available information and is intended as a reference for evaluating tools. Features, pricing, and related policies may change at any time; please refer to the latest official information.
Original source:www.accessdata.fda.gov